|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Rig materials and supplies | ||||||||||||||||||||
| Deferred costs | ||||||||||||||||||||
| Other tax assets | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net (Note 4) | ||||||||||||||||||||
| Goodwill (Note 4) | ||||||||||||||||||||
| Intangible assets, net (Note 5) | ||||||||||||||||||||
| Rig materials and supplies | ||||||||||||||||||||
| Debt issuance costs | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Debtor in possession financing (Note 2) | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Total accounts payable and accrued liabilities | ||||||||||||||||||||
| Accrued income taxes | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt (Note 8) | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Long-term deferred tax liability | ||||||||||||||||||||
| Commitments and contingencies (Note 11) | ||||||||||||||||||||
| Total liabilities not subject to compromise | ||||||||||||||||||||
| Liabilities subject to compromise (Note 2) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Common Stock, $0.16 2/3 par value, authorized 280,000,000 shares, issued and outstanding, 138,935,734 shares (125,118,365 shares in 2016) | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Successor common stock, $0.01 par value, 500,000,000 shares authorized, 15,044,739 shares issued and outstanding | ||||||||||||||||||||
| Successor capital in excess of par value | ||||||||||||||||||||
| Retained earnings (accumulated deficit) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
